Neurodevelopmental diseases may result from early brain injury or abnormal brain development.
Some of the illnesses in this group can be treated effectively and promptly with pharmaceutical or nonpharmacological therapies, whilst others are chronic and require lifelong management.
You will create a study guide for a disorder that has been assigned as part of this assignment and distribute it to your peers. As a whole, these study aids will be an effective resource for getting ready for your certification exam.
Photo credit: iStockphoto/Getty Images
To Get Ready
· You will be assigned by your instructor to a certain DSM-5 neurodevelopmental condition.
· Utilize the Walden Library to learn more about the assigned disease. Create a system of organizing for the crucial facts on the disorder next.
What Was Done
Make a study guide for the disorder you were given. You should include visual aids like concept maps, charts, infographics, photos, color coding, mnemonics, and/or flashcards in your study guide. It should take the form of an overview with references. Be original! It shouldn’t follow the guidelines for an APA paper. The DSM-5 should serve as a foundation for your guide, but it should also be backed by at least three other academic sources.
Areas of importance you should address, but are not limited to, are:
· Signs and symptoms according to the DSM-5
· Differential diagnoses
· Incidence
· Development and course
· Prognosis
· Considerations related to culture, gender, age
· Pharmacological treatments, including any side effects
· Nonpharmacological treatments
· Diagnostics and labs
· Comorbidities
· Legal and ethical considerations
· Pertinent patient education considerations
By Day 7 of Week 8
Submit your Assignment to the forum as an attachment. Although no responses are required, collegial
discussion is welcome. You are encouraged to utilize your peers’ submitted guides on their assigned
neurodevelopmental disorders for study.
Submission and Grading Information
Grading Criteria
Also Read: NRNP 6635 Assignment Assessing and Diagnosing Patients With Mood Disorders
To access your rubric:
Week 8 Assignment Rubric
Post by Day 7 of Week 8
To Participate in this Assignment:
Week 8 Assignment
What’s Coming Up in Week 9?
In Week 9, you will analyze clinical, ethical, and legal issues related to diagnosing and treating
dissociative disorders.
Photo Credit: [BrianAJackson]/[iStock / Getty Images Plus]/Getty Images
Next Week
To go to the next week:
Week 9
Learning Resources
Required Readings (click to expand/reduce)
Hilt, R. J., & Nussbaum, A. M. (2016). DSM-5 pocket guide for child and adolescent mental health.
American Psychiatric Association Publishing.
· Chapter 12, “Developmental Milestones”
Thapar, A., Pine, D. S., Leckman, J. F., Scott, S., Snowling, M. J., & Taylor, E. A. (2015). Rutter’s child and
adolescent psychiatry (6th ed.). Wiley Blackwell.
· Chapter 51, “Autism Spectrum Disorder”
· Chapter 55, “ADHD and Hyperkinetic Disorder”
Utah State University. (n.d.). Creating study guides. https://www.usu.edu/academic-
support/test/creating_study_guides
Walden University. (2020). Success strategies: Self-paced interactive tutorials.
https://academicguides.waldenu.edu/academic-skills-center/skills/tutorials/success-strategies
Zakhari, R. (2020). The psychiatric-mental health nurse practitioner certification review manual. Springer.
· Chapter 13, “Child/Adolescent Neurodevelopmental Disorders”
Required Media (click to expand/reduce)
Dillon, K. (2019, March 23). DSM-5 neurodevelopmental disorders. [Video]. YouTube.
The National Center for Learning Disabilities. (2013, February 20). What is ADHD? [Video]. YouTube.
Osmosis. (2017, October 17). Autism – causes, symptoms, diagnosis, treatment, pathology [Video].
YouTube. https://youtu.be/x2hWVgZ8J4A
Medication Review
Irritability in autism Attention-deficit/hyperactivity disorder
aripiprazole
risperidone
amphetamine IR, XR, and ER
dextroamphetamine
atomoxetine
clonidine hydrocholoride ER
Dexmethylphenidate IR and XR
guanfacine hydrocholride ER
lisdexamfetamine
methylphenidate
methylphenidate hydrocholoride IR and ER, transdermal
